• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基层医疗中慢性偏头痛的诊断与管理。

The Diagnosis and Management of Chronic Migraine in Primary Care.

机构信息

Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

出版信息

Headache. 2017 Oct;57(9):1471-1481. doi: 10.1111/head.13089. Epub 2017 May 26.

DOI:10.1111/head.13089
PMID:28548676
Abstract

BACKGROUND

Chronic migraine is common, affecting approximately 1% of the general population, and causes significant disability.

OBJECTIVE

To summarize optimal involvement of primary care physicians in chronic migraine care, and to provide algorithms to assist them in the diagnosis and management of patients with chronic migraine.

METHODS

An analysis of diagnostic and treatment needs in chronic migraine, based on a synthesis of the medical literature and clinical experience.

RESULTS

Chronic migraine represents the more severe end of the migraine spectrum, usually arises out of previous episodic migraine, and is characterized by headache on 15 days a month or more. Importantly, the headache needs to meet migraine diagnostic criteria on only 8 days a month in order to meet chronic migraine diagnostic criteria. When acute medication overuse is present, a second diagnosis of medication overuse headache should be made. If patients meet criteria for chronic migraine, this excludes a diagnosis of chronic tension-type headache. Acute therapy of chronic migraine is similar to episodic migraine, except that medication overuse is a much greater risk in chronic migraine and must be addressed. All patients should be considered for pharmacological prophylaxis, and the behavioral aspects of therapy should be emphasized. The two prophylactic drugs with the best evidence for efficacy in chronic migraine are topiramate and onabotulinumtoxinA. Given the disability caused by chronic migraine, these should both be available to patients as necessary.

CONCLUSION

Management of chronic migraine is complex, and many patients are relatively refractory to therapy. Specialist referral will often be required and should not be unduly delayed. On the other hand, the primary care physician should be able to make the diagnosis, initiate therapy, and manage some less refractory patients without referral. The timing of referral should depend both on the expertise of the primary care physician in headache management and the patient's response to initial therapy.

摘要

背景

慢性偏头痛较为常见,影响约 1%的普通人群,且可导致严重残疾。

目的

总结初级保健医生在慢性偏头痛治疗中的最佳参与方式,并提供相关算法以协助他们诊断和管理慢性偏头痛患者。

方法

基于对慢性偏头痛的诊断和治疗需求的分析,综合了医学文献和临床经验。

结果

慢性偏头痛代表偏头痛谱中更严重的一端,通常由先前的阵发性偏头痛发展而来,其特征为每月头痛 15 天或以上。重要的是,即使每月头痛满足偏头痛诊断标准的天数仅为 8 天,也可满足慢性偏头痛的诊断标准。当存在急性药物过度使用时,应做出药物过度使用性头痛的第二诊断。如果患者符合慢性偏头痛标准,则排除慢性紧张型头痛的诊断。慢性偏头痛的急性治疗与阵发性偏头痛相似,但药物过度使用是慢性偏头痛的一个更大风险,必须加以解决。所有患者均应考虑药物预防治疗,并应强调治疗的行为方面。在慢性偏头痛中,具有最佳疗效证据的两种预防药物是托吡酯和肉毒杆菌毒素 A。鉴于慢性偏头痛所致的残疾,必要时应向患者提供这两种药物。

结论

慢性偏头痛的管理较为复杂,许多患者对治疗的反应相对较差。通常需要专科转诊,且不应延迟。另一方面,初级保健医生应能够在无需转诊的情况下做出诊断、启动治疗并管理一些对治疗反应较好的患者。转诊时机应取决于初级保健医生头痛管理的专业知识以及患者对初始治疗的反应。

相似文献

1
The Diagnosis and Management of Chronic Migraine in Primary Care.基层医疗中慢性偏头痛的诊断与管理。
Headache. 2017 Oct;57(9):1471-1481. doi: 10.1111/head.13089. Epub 2017 May 26.
2
Headache diagnosis, management and morbidity in the Singapore primary care setting: findings from a general practice survey.新加坡基层医疗环境中头痛的诊断、管理及发病率:一项全科医疗调查的结果
Singapore Med J. 2008 Oct;49(10):774-9.
3
Best practices for patients with chronic migraine: burden, diagnosis, and management in primary care.慢性偏头痛患者的最佳实践:初级保健中的负担、诊断和管理。
Mayo Clin Proc. 2015 Mar;90(3):408-14. doi: 10.1016/j.mayocp.2015.01.010.
4
Providing Care for Patients with Chronic Migraine: Diagnosis, Treatment, and Management.为慢性偏头痛患者提供护理:诊断、治疗与管理
Pain Pract. 2015 Sep;15(7):688-92. doi: 10.1111/papr.12243. Epub 2014 Oct 1.
5
Diagnosing and managing migraine headache.偏头痛的诊断与管理
J Am Osteopath Assoc. 2007 Nov;107(10 Suppl 6):ES10-6.
6
Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features.偏头痛诊断和治疗的障碍:性别、收入和头痛特征的影响。
Headache. 2013 Jan;53(1):81-92. doi: 10.1111/j.1526-4610.2012.02265.x. Epub 2012 Oct 18.
7
Considerations for management of migraine symptoms in the primary care setting.基层医疗环境中偏头痛症状管理的考量因素。
Postgrad Med. 2016 Jun;128(5):523-37. doi: 10.1080/00325481.2016.1175912. Epub 2016 May 10.
8
Headache evaluation and treatment by primary care physicians in an emergency department in the era of triptans.曲坦类药物时代急诊科初级保健医生对头痛的评估与治疗
Arch Intern Med. 2001 Sep 10;161(16):1969-73. doi: 10.1001/archinte.161.16.1969.
9
Chronic migraine: current concepts and ongoing treatments.慢性偏头痛:当前的概念和正在进行的治疗。
Eur Rev Med Pharmacol Sci. 2011 Dec;15(12):1401-20.
10
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.肉毒杆菌毒素 A 治疗慢性偏头痛:PREEMPT 临床研究计划双盲、随机、安慰剂对照阶段的汇总结果。
Headache. 2010 Jun;50(6):921-36. doi: 10.1111/j.1526-4610.2010.01678.x. Epub 2010 May 7.

引用本文的文献

1
Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data.肉毒毒素 A(保妥适®)预防治疗慢性偏头痛的有效性:基于 10 年真实世界数据的荟萃分析。
Cephalalgia. 2022 Dec;42(14):1543-1564. doi: 10.1177/03331024221123058. Epub 2022 Sep 8.
2
Practical Insights on the Identification and Management of Patients with Chronic Migraine.慢性偏头痛患者识别与管理的实践见解
Pain Ther. 2022 Jun;11(2):447-457. doi: 10.1007/s40122-022-00387-9. Epub 2022 Apr 20.
3
Activation of microglial GLP-1R in the trigeminal nucleus caudalis suppresses central sensitization of chronic migraine after recurrent nitroglycerin stimulation.
反复给予硝化甘油刺激后,三叉神经脊束尾核小胶质细胞 GLP-1R 的激活抑制了慢性偏头痛的中枢敏化。
J Headache Pain. 2021 Jul 29;22(1):86. doi: 10.1186/s10194-021-01302-x.
4
Analysis of treatment cost and persistence among migraineurs: A two-year retrospective cohort study in Pakistan.偏头痛患者的治疗成本与持续性分析:巴基斯坦一项为期两年的回顾性队列研究。
PLoS One. 2021 Mar 26;16(3):e0248761. doi: 10.1371/journal.pone.0248761. eCollection 2021.
5
Levels and determinants of knowledge about chronic migraine diagnosis and management among primary health-care physicians in ministry of health, Jeddah 2019.2019年吉达市卫生部初级保健医生对慢性偏头痛诊断与管理的知识水平及影响因素
J Family Med Prim Care. 2020 May 31;9(5):2324-2331. doi: 10.4103/jfmpc.jfmpc_266_20. eCollection 2020 May.
6
Validation of an algorithm for automated classification of migraine and tension-type headache attacks in an electronic headache diary.验证一种用于电子头痛日记中偏头痛和紧张型头痛发作自动分类的算法。
J Headache Pain. 2020 Jun 12;21(1):75. doi: 10.1186/s10194-020-01139-w.
7
Factors Affecting Preventive Treatment Outcomes for Patients With Newly Diagnosed Chronic Migraine and Their Compliance With Treatment Recommendations in Chongqing Province, China: An Open-Label Prospective Study With Retrospective Baseline.影响中国重庆市新诊断慢性偏头痛患者预防性治疗效果及其对治疗建议依从性的因素:一项具有回顾性基线的开放标签前瞻性研究
Front Neurol. 2020 Apr 9;11:227. doi: 10.3389/fneur.2020.00227. eCollection 2020.
8
An Evidence-Based Review of Fremanezumab for the Treatment of Migraine.一项关于fremanezumab治疗偏头痛的循证综述。
Pain Ther. 2020 Jun;9(1):195-215. doi: 10.1007/s40122-020-00159-3. Epub 2020 Mar 28.
9
P2Y12 receptor mediates microglial activation via RhoA/ROCK pathway in the trigeminal nucleus caudalis in a mouse model of chronic migraine.P2Y12 受体通过 RhoA/ROCK 通路介导三叉神经尾核小胶质细胞激活,参与慢性偏头痛小鼠模型的发病机制。
J Neuroinflammation. 2019 Nov 13;16(1):217. doi: 10.1186/s12974-019-1603-4.
10
A Prospective Observational Cohort Study on Pharmacological Habitus, Headache-Related Disability and Psychological Profile in Patients with Chronic Migraine Undergoing OnabotulinumtoxinA Prophylactic Treatment.一项关于慢性偏头痛患者接受肉毒毒素 A 预防性治疗的药物习性、头痛相关残疾和心理特征的前瞻性观察性队列研究。
Toxins (Basel). 2019 Aug 29;11(9):504. doi: 10.3390/toxins11090504.